US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

22.43

-0.9900-4.23%

Post-market: 22.430.00000.00%16:10 EDT

Volume:52.59K

Turnover:1.20M

Market Cap:85.87M

PE:-0.85

High:23.62

Open:23.35

Low:22.09

Close:23.42

52wk High:37.50

52wk Low:18.19

Shares:3.83M

Float Shares:1.07M

Volume Ratio:1.20

T/O Rate:4.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-26.3603

EPS(LYR):-23.0359

ROE:-333.84%

ROA:-49.98%

PB:-57.21

PE(LYR):-0.97

Loading ...

Overview Company News Filings

Pelthos Therapeutics files Form 3 for CFO John M. Gay

Pelthos CEO to hold investor meetings at Piper Sandler Spring Biopharma Symposium

BRIEF-Pelthos Therapeutics Announces CFO Transition

Pelthos names John Gay CFO, replacing Francis Knuettel II

Pelthos Therapeutics Inc - Appoints John M. Gay as CFO Effective April 10, 2026

THOMSON REUTERS

Top Premarket Decliners

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), IDEAYA Biosciences (IDYA) and Viridian Therapeutics (VRDN)

Pelthos Therapeutics doses first patient in CT2000 trial

BRIEF-Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain

Pelthos Therapeutics Announces First Patient Dosed in Phase 1B/2a Clinical Trial of Ct2000 in Eye Pain

THOMSON REUTERS

Pelthos Therapeutics Inc - Results From Phase 1B/2a Ct2000 Trial Anticipated at End of 2026

THOMSON REUTERS

Alliance Global Partners Keeps Their Buy Rating on Pelthos Therapeutics (PTHS)

Pelthos Therapeutics Inc trading resumes

Analysts Offer Insights on Healthcare Companies: Community Health (CYH) and Pelthos Therapeutics (PTHS)

Lake Street Sticks to Their Buy Rating for Pelthos Therapeutics (PTHS)

Pelthos Therapeutics Inc. : Oppenheimer Raises Target Price to $62 From $60

THOMSON REUTERS

BRIEF-Pelthos Therapeutics Announces Fourth Quarter And Full Year 2025 Financial Results

Pelthos Q4 net loss widens to USD 21.66 million as ZELSUVMI net product revenue rises 28% to USD 9.09 million

Refile- Pelthos Therapeutics Inc Qtrly Total Revenue $9.4 Mln (Adds Dropped Currency)

THOMSON REUTERS

Pelthos Therapeutics Inc: Have Commercial Infrastructure and Experience to Continue to Grow Zelsuvmi and Launch and Grow Xepi and Xeglyze

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/PTHS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":22.43,"timestamp":1789070400000,"preClose":23.42,"halted":0,"volume":52588,"hourTrading":{"tag":"盘后","latestPrice":22.43,"preClose":22.43,"latestTime":"16:10 EDT","volume":8,"amount":179.44,"timestamp":1789071008280,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04227156276686601,"floatShares":1065500,"shares":3828500,"eps":-26.360256,"marketStatus":"Post-Mkt","change":-0.99,"latestTime":"09-10 18:46:14 EDT","open":23.35,"high":23.62,"low":22.09,"amount":1198910,"amplitude":0.065329,"askPrice":22.87,"askSize":1,"bidPrice":9.37,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-26.360256,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":23.42,"preHourTrading":{"tag":"盘前","latestPrice":24.22,"preClose":23.42,"latestTime":"09:06 EDT","volume":20,"amount":536.97,"timestamp":1789045560859,"change":0.8,"changeRate":0.034159,"amplitude":0.289069},"postHourTrading":{"tag":"盘后","latestPrice":22.43,"preClose":22.43,"latestTime":"16:10 EDT","volume":8,"amount":179.44,"timestamp":1789071008280,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.204153},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":1065500,"roa":"-49.98%","roe":"-333.84%","lyrEps":-23.035919,"volumeRatio":1.204153,"shares":3828500,"dividePrice":0,"high":23.62,"amplitude":0.065329,"preClose":23.42,"low":22.09,"week52Low":18.19,"pbRate":"-57.21","psRate":"1.98","week52High":37.5,"institutionHeld":0,"latestPrice":22.43,"committee":0.99005,"eps":-26.360256,"divideRate":0,"volume":52588,"delay":0,"ttmEps":-26.360256,"open":23.35,"prevYearClose":31,"prevWeekClose":24.35,"prevMonthClose":24.08,"prevQuarterClose":28.26,"fiveDayClose":25.03,"twentyDayClose":28.91,"sixtyDayClose":26.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PTHS","fiscalQuarterEnding":"2026/06","expectedEps":-3.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-6.62},{"market":"US","date":"2026-05-14","symbol":"PTHS","fiscalQuarterEnding":"2026/03","expectedEps":4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-3.09},{"market":"US","date":"2026-03-19","symbol":"PTHS","fiscalQuarterEnding":"2025/12","expectedEps":-3.95,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-2.83},{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1775102400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-09-09","current":-0.850902,"percent":0.979798,"low":-12.702408,"twenty":-3.993187,"median":-1.978972,"eighty":-1.758296,"high":-1.038767,"avg":-3.818817,"sd":3.320352,"marketCap":93988913},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-13","current":-2.833747,"twenty":-10.623674,"median":-3.435432,"eighty":-1.954036,"marketCap":66823556},{"date":"2026-02-20","current":-3.036408,"twenty":-10.612903,"median":-3.401675,"eighty":-1.95977,"marketCap":71602566},{"date":"2026-02-27","current":-3.155779,"twenty":-10.602805,"median":-3.390837,"eighty":-1.970524,"marketCap":74417489},{"date":"2026-03-06","current":-3.074826,"twenty":-10.434506,"median":-3.374475,"eighty":-1.97142,"marketCap":72508518},{"date":"2026-03-13","current":-3.190081,"twenty":-10.434506,"median":-3.360076,"eighty":-1.972316,"marketCap":75226374},{"date":"2026-03-20","current":-1.7154,"twenty":-10.097909,"median":-3.349516,"eighty":-1.97142,"marketCap":74309421},{"date":"2026-03-27","current":-1.761468,"twenty":-9.761313,"median":-3.316998,"eighty":-1.911381,"marketCap":76305047},{"date":"2026-04-02","current":-1.649924,"twenty":-9.626674,"median":-3.312954,"eighty":-1.88181,"marketCap":71473065},{"date":"2026-04-10","current":-1.749075,"twenty":-9.525695,"median":-3.297807,"eighty":-1.833421,"marketCap":75768160},{"date":"2026-04-17","current":-1.781608,"twenty":-9.500787,"median":-3.280885,"eighty":-1.792379,"marketCap":77177489},{"date":"2026-04-24","current":-1.797101,"twenty":-9.439526,"median":-3.26405,"eighty":-1.781608,"marketCap":77848597},{"date":"2026-05-01","current":-1.936531,"twenty":-9.424716,"median":-3.220673,"eighty":-1.782538,"marketCap":83888575},{"date":"2026-05-08","current":-1.938855,"twenty":-9.37086,"median":-3.190081,"eighty":-1.785296,"marketCap":83989241},{"date":"2026-05-15","current":-2.144901,"twenty":-9.354703,"median":-3.188002,"eighty":-1.78619,"marketCap":92914985},{"date":"2026-05-22","current":-1.825776,"twenty":-9.310946,"median":-3.162639,"eighty":-1.782538,"marketCap":94189979},{"date":"2026-05-29","current":-1.738193,"twenty":-9.201215,"median":-3.155779,"eighty":-1.782305,"marketCap":89671641},{"date":"2026-06-05","current":-1.742235,"twenty":-9.106968,"median":-3.138864,"eighty":-1.781608,"marketCap":89880179},{"date":"2026-06-12","current":-1.934919,"twenty":-9.053119,"median":-3.057709,"eighty":-1.781608,"marketCap":99820524},{"date":"2026-06-18","current":-1.819713,"twenty":-9.002347,"median":-3.051164,"eighty":-1.781608,"marketCap":93877171},{"date":"2026-06-26","current":-1.967931,"twenty":-8.742683,"median":-3.016477,"eighty":-1.781608,"marketCap":101523590},{"date":"2026-07-02","current":-1.886411,"twenty":-8.328756,"median":-3.009278,"eighty":-1.781608,"marketCap":97318060},{"date":"2026-07-10","current":-1.829819,"twenty":-7.979401,"median":-2.945794,"eighty":-1.781608,"marketCap":94398518},{"date":"2026-07-17","current":-1.799501,"twenty":-7.934399,"median":-2.91896,"eighty":-1.781608,"marketCap":92834477},{"date":"2026-07-24","current":-1.91336,"twenty":-7.821168,"median":-2.887545,"eighty":-1.781608,"marketCap":98708318},{"date":"2026-07-31","current":-1.76851,"twenty":-7.788854,"median":-2.833747,"eighty":-1.781608,"marketCap":91235681},{"date":"2026-08-07","current":-1.9841,"twenty":-7.738365,"median":-2.592541,"eighty":-1.781608,"marketCap":102357745},{"date":"2026-08-14","current":-1.950414,"twenty":-7.559968,"median":-2.325379,"eighty":-1.781608,"marketCap":100619922},{"date":"2026-08-21","current":-1.18144,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"marketCap":102066983},{"date":"2026-08-28","current":-1.107877,"twenty":-4.131996,"median":-1.987469,"eighty":-1.771879,"marketCap":95711725},{"date":"2026-09-04","current":-1.079516,"twenty":-4.057747,"median":-1.983517,"eighty":-1.761468,"marketCap":93261504},{"date":"2026-09-09","current":-1.087935,"twenty":-3.993187,"median":-1.978972,"eighty":-1.758296,"marketCap":93988913}],"updateTime":1789080374890},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629796317","title":"Pelthos Therapeutics files Form 3 for CFO John M. Gay","url":"https://stock-news.laohu8.com/highlight/detail?id=2629796317","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629796317?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:01","pubTimestamp":1776718883,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics CFO John M. Gay reported 30,518 common shares in an initial Form 3 filing.Filing also listed stock options for 93,000 shares with an exercise price of $13.5.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL5N643x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627446258","title":"Pelthos CEO to hold investor meetings at Piper Sandler Spring Biopharma Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2627446258","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627446258?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:36","pubTimestamp":1776170176,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics CEO Scott Plesha will hold one-on-one investor meetings at Piper Sandler Spring Biopharma Symposium on April 16, 2026 in Boston.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL7Gwkv9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4139","BK4112","LU2095319765.USD","BK4127","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4588","IE00BN0W2T93.GBP","NDAQ","LU2210150020.SGD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4585","SG9999014039.USD","SG9999014013.SGD","PIPR","PTHS","LU0053671581.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626433021","title":"BRIEF-Pelthos Therapeutics Announces CFO Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2626433021","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626433021?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:00","pubTimestamp":1775854847,"startTime":"0","endTime":"0","summary":"BRIEF-Pelthos Therapeutics Announces CFO TransitionApril 10 (Reuters) - Pelthos Therapeutics Inc PTHS.A:PELTHOS THERAPEUTICS ANNOUNCES CFO TRANSITIONPELTHOS THERAPEUTICS INC - APPOINTS JOHN M. GAY AS ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA4HPM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626300143","title":"Pelthos names John Gay CFO, replacing Francis Knuettel II","url":"https://stock-news.laohu8.com/highlight/detail?id=2626300143","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626300143?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:00","pubTimestamp":1775854819,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics appointed John M. Gay as chief financial officer, effective April 10, 2026.Gay succeeds Francis Knuettel II, who has served as CFO since July 2025.Gay has been senior vice president, finance and accounting at Pelthos since 2025.His prior roles include CFO of LNHC and senior finance positions at publicly traded companies such as Furiex Pharmaceuticals.Gay previously worked at Deloitte and Arthur Andersen.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL8cmbZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LU0942090050.USD","LU2089984988.USD","LU2133065610.SGD","LU2210149790.SGD","LU1003077747.HKD","LU0738911758.USD","IE00BVYPNV92.GBP","NDAQ","IE00B19Z3B42.SGD","IE0002141913.USD","LU1430594728.SGD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU1983299246.USD","LU0170899867.USD","LU0795875169.SGD","LU0234570918.USD","600212","IE00BVYPNW00.USD","IE00BN8TJ469.HKD","LU0029864427.USD","LU0511384066.AUD","SG9999015945.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","LU2237443549.SGD","LU2089284900.SGD","LU0545039389.USD","IE00BBT3K403.USD","LU1551013425.SGD","LU1037948897.HKD","LU1061106388.HKD","LU2237443382.USD","LU0689626769.HKD","BK4588","LU2237443465.HKD","PTHS","LU0124676726.USD","LU0256863811.USD","LU0965509010.AUD","LU1244550577.SGD","LU1023059063.AUD","BK4566","LU0456855351.SGD","SG9999014021.USD","IE0004445239.USD","IE00BJT1NW94.SGD","LU0310799852.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626114337","title":"Pelthos Therapeutics Inc - Appoints John M. Gay as CFO Effective April 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626114337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626114337?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:00","pubTimestamp":1775854800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA4HPM5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625372649","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2625372649","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625372649?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:46","pubTimestamp":1775562415,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics (PTHS) shares were 18% lower pre-bell Tuesday, erasing Monday's rally.Focus Universal (FCUV) stock was down 18%, paring gains from the previous session.Biodexa Pharmaceuticals (BDRX) shares were 13% lower, extending Monday's losses.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDRX","FCUV","PTHS","BK4157","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676770","title":"Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), IDEAYA Biosciences (IDYA) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676770?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:30","pubTimestamp":1775475008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pelthos Therapeutics (PTHS), IDEAYA Biosciences (IDY...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pelthos-therapeutics-pths-ideaya-biosciences-idya-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pelthos-therapeutics-pths-ideaya-biosciences-idya-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA","BK4139","LABU","BK4137","HCSG","LU0128526141.USD","BK4585","BK4588","BK4581","PTHS","VRDN","XBI","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623432580","title":"Pelthos Therapeutics doses first patient in CT2000 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2623432580","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623432580?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:21","pubTimestamp":1774966872,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics (PTHS) announced that the first patient has been dosed in a Phase 1b/2a clinical trial evaluating CT2000 as a potential treatm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pelthos-therapeutics-doses-first-patient-in-ct2000-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pelthos-therapeutics-doses-first-patient-in-ct2000-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","PTHS","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623581452","title":"BRIEF-Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2623581452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623581452?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:43","pubTimestamp":1774961009,"startTime":"0","endTime":"0","summary":"BRIEF-Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye PainMarch 31 (Reuters) - Pelthos Therapeutics Inc PTHS.A:PELTHOS THERAPEUTICS ANNOUNCES FIRST PA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA3FCZ6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623581801","title":"Pelthos Therapeutics Announces First Patient Dosed in Phase 1B/2a Clinical Trial of Ct2000 in Eye Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2623581801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623581801?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:30","pubTimestamp":1774960200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA3FCZ6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623581316","title":"Pelthos Therapeutics Inc - Results From Phase 1B/2a Ct2000 Trial Anticipated at End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623581316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623581316?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:30","pubTimestamp":1774960200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA3FCZ6P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623077314","title":"Alliance Global Partners Keeps Their Buy Rating on Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623077314","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623077314?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:37","pubTimestamp":1774870648,"startTime":"0","endTime":"0","summary":"In a report released today, James Molloy from Alliance Global Partners reiterated a Buy rating on Pelthos Therapeutics, with a price target of $75....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-keeps-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-keeps-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621707990","title":"Pelthos Therapeutics Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621707990?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:15","pubTimestamp":1774278922,"startTime":"0","endTime":"0","summary":"11:13 EDT Pelthos Therapeutics (PTHS) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pelthos-therapeutics-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pelthos-therapeutics-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","PTHS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621717736","title":"Analysts Offer Insights on Healthcare Companies: Community Health (CYH) and Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621717736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621717736?lang=en_us&edition=fundamental","pubTime":"2026-03-22 21:20","pubTimestamp":1774185606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Community Health (CYH) and Pelthos Therapeutics (PTH...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-community-health-cyh-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-community-health-cyh-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CYH","HCSG","BK4137","XBI","LU0128526141.USD","BK4139","LABU","XLV","LU0029874061.USD","PTHS","BK4588","BK4581","BK4585","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620739234","title":"Lake Street Sticks to Their Buy Rating for Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620739234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620739234?lang=en_us&edition=fundamental","pubTime":"2026-03-20 21:15","pubTimestamp":1774012545,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Flaten from Lake Street reiterated a Buy rating on Pelthos Therapeutics, with a price target of $50.00. Accordin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-their-buy-rating-for-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-their-buy-rating-for-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620359617","title":"Pelthos Therapeutics Inc. : Oppenheimer Raises Target Price to $62 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2620359617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620359617?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:20","pubTimestamp":1774009218,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nAZN4SMETI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247720","title":"BRIEF-Pelthos Therapeutics Announces Fourth Quarter And Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247720?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:02","pubTimestamp":1773921732,"startTime":"0","endTime":"0","summary":"BRIEF-Pelthos Therapeutics Announces Fourth Quarter And Full Year 2025 Financial ResultsMarch 19 (Reuters) - Pelthos Therapeutics Inc PTHS.A:PELTHOS THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA2XJW8N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620249467","title":"Pelthos Q4 net loss widens to USD 21.66 million as ZELSUVMI net product revenue rises 28% to USD 9.09 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620249467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620249467?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:30","pubTimestamp":1773916236,"startTime":"0","endTime":"0","summary":"Pelthos published a press release reporting Q4 and FY 2025 financial results.Q4 net product revenues were USD 9.09 million, up 28% quarter over quarter.Q4 operating loss narrowed to USD 12.00 million and net loss was USD 21.66 million.FY total revenue was USD 16.8 million, including USD 16.21 million in net product revenues.From ZELSUVMI’s July launch through year-end, net product revenue totaled USD 16.2 million and units dispensed rose 129% quarter over quarter to 6,232, despite a seasonal reduction in patients seeking molluscum contagiosum treatment, management said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6vxkqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4139","PTHS","BK4112","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","SG9999014039.USD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620924751","title":"Refile- Pelthos Therapeutics Inc Qtrly Total Revenue $9.4 Mln (Adds Dropped Currency)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620924751?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:30","pubTimestamp":1773916201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA2XJW8N:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620249211","title":"Pelthos Therapeutics Inc: Have Commercial Infrastructure and Experience to Continue to Grow Zelsuvmi and Launch and Grow Xepi and Xeglyze","url":"https://stock-news.laohu8.com/highlight/detail?id=2620249211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620249211?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:30","pubTimestamp":1773916201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA2XJW8N:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":64,"code":"91000000","status":"200"}]}}